NA-Semax Amidate
- Category
- Brain & Cognition
- Administration routes
- Nasal
- Regulatory status
- Not FDA-approved
What it is
A stabilized, injectable analog of Semax marketed for focus, cognitive enhancement, and stroke neuroprotection. Its best support comes from stroke recovery (improved outcomes with elevated BDNF), but claims about blood flow, brain connectivity, and memory gains rest on thin human data or mechanism studies alone. Safety data on this NA-Amidate form is essentially absent. Not an approved drug in the US; supply is largely unregulated research-grade peptide.
Read Full recordStudied uses & evidence
Studied uses(6)
Neuroprotection in stroke — improved outcomes and elevated BDNF in clinical use
MediumSmall, unblinded human trials in stroke patients reported faster recovery and raised BDNF.
Increased BDNF and NGF expression in hippocampus and frontal cortex
MediumExtensive animal data, mostly one research lineage, with supportive human plasma BDNF findings.
Default mode network changes reported with parent Semax; benefit for NA-Semax Amidate is unestablished
SpeculativeDMN connectivity shifts were shown for parent compound Semax, not tested directly in NA-Semax Amidate.
Evidence limits
- Evidence Level
- Very Limited Evidence
Semax has been used clinically in Russia for over two decades for stroke, TBI, and cognitive disorders. However, most clinical data is published in Russian-language journals with limited English translations. Key clinical findings include improved neurological outcomes in stroke patients (n=110) and increased BDNF levels. An fMRI study in healthy subjects showed neural connectivity changes with intranasal Semax. The ADDF notes that 'published literature of well-conducted studies is lacking' in English. NA-Semax Amidate has not been tested in clinical trials.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(3)
Risks = level of concern: High · Moderate · Low · Theoretical
Limited safety data on the specific NA-Amidate form
HighPotential serotonergic and dopaminergic effects
LowMethionine oxidation (specific to Semax/NA-Semax)
Theoretical
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.